Non-transcriptional control of DNA replication by c-Myc
Top Cited Papers
- 27 June 2007
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 448 (7152) , 445-451
- https://doi.org/10.1038/nature05953
Abstract
The c-Myc proto-oncogene encodes a transcription factor that is essential for cell growth and proliferation and is broadly implicated in tumorigenesis. However, the biological functions required by c-Myc to induce oncogenesis remain elusive. Here we show that c-Myc has a direct role in the control of DNA replication. c-Myc interacts with the pre-replicative complex and localizes to early sites of DNA synthesis. Depletion of c-Myc from mammalian (human and mouse) cells as well as from Xenopus cell-free extracts, which are devoid of RNA transcription, demonstrates a non-transcriptional role for c-Myc in the initiation of DNA replication. Overexpression of c-Myc causes increased replication origin activity with subsequent DNA damage and checkpoint activation. These findings identify a critical function of c-Myc in DNA replication and suggest a novel mechanism for its normal and oncogenic functions.Keywords
This publication has 52 references indexed in Scilit:
- Large-Scale Identification of c-MYC-Associated Proteins Using a Combined TAP/MudPIT ApproachCell Cycle, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- DNA replication: the unbearable lightness of originsEMBO Reports, 2006
- Excess Mcm2–7 license dormant origins of replication that can be used under conditions of replicative stressThe Journal of cell biology, 2006
- Myc influences global chromatin structureThe EMBO Journal, 2006
- Activation of the DNA damage checkpoint and genomic instability in human precancerous lesionsNature, 2005
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesisNature, 2005
- Analysis of genomic targets reveals complex functions of MYCNature Reviews Cancer, 2004
- ParcCell, 2003
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985